Skip to content
OpenCapital
Get started

Denali Therapeutics Inc. DNLI EBITDA

EBITDA at other companies

uniQure logo
uniQureQURE
-$42.76M-22.9%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$60.37M-93.8%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
-$124.73M-2.3%
Eli Lilly logo
Eli LillyLLY
——
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
——
BridgeBio Pharma logo
BridgeBio PharmaBBIO
——

Other financials

Income statement

See full
Revenue-—
Operating income-$137.4M+5.6%
Net income-$128.4M+3.4%
EPS (diluted)-$0.69+11.5%

Balance sheet

See full
Cash & equivalents$390.7M+551%
Total debt$40.0M-22.3%
Total equity$926.1M-17.5%
Total assets$1.3B-0.4%

Cash flow

See full
Operating cash flow-$131.2M+0.2%
CapEx$2.5M-51.4%
Free cash flow-$133.7M+2.1%

Valuation

See full
Market cap$3.93B+54.2%

Profitability

See full
Operating margin-37,938%-37,986pp
Net margin-33,121.9%-33,159pp
FCF margin-31,736.3%-31,830pp

Returns & leverage

See full
Return on equity-49.6%+34.2pp
Debt / equity0×0.0×
Current ratio9.3×-0.3×

Where this comes from

Calculated from Denali Therapeutics Inc.’s reported figures.

−$137.4Mebit+
$2.8MDepreciation Depletion & Amortization
=-$134.51M

The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Denali Therapeutics Inc.'s ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Denali Therapeutics Inc.'s EBITDA?
Denali Therapeutics Inc. (DNLI) reported EBITDA of -$134.51M in Q1 2026.
How has Denali Therapeutics Inc.'s EBITDA changed year-over-year?
Denali Therapeutics Inc.'s EBITDA increased by 6.1% year-over-year, from -$143.26M to -$134.51M.
What is the long-term trend for Denali Therapeutics Inc.'s EBITDA?
Over 4 years (2021 to 2025), Denali Therapeutics Inc.'s EBITDA has grown at a 17.3% compound annual growth rate (CAGR), from -$287.16M to -$544.16M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.